Výsledky vyhledávání - "Emiel van Heumen"

Safety Evaluation in Iterative Development of Wearable Sensors for Aripiprazole Tablets with Sensor: Pooled Analysis of Clinical Trials (Preprint)

Autor: Michael Jan, Antonia K Coppin-Renz, Robin West, Christophe Le Gallo, Jeffrey M Cochran, Emiel van Heumen, Michael Fahmy, J Corey Reuteman-Fowler

BACKGROUND Wearable sensors in digital health help facilitate real-time, point-of-care monitoring. However, wearable sensors may pose a risk for skin irritation through the use of adhesive patches. Little is known about how patient- and product-relat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42484976ae2d39899b9575971eebfc5f
https://doi.org/10.2196/preprints.44768

Zobrazit plný text záznamu

Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study

Autor: Timothy Peters-Strickland, Antonia Coppin-Renz, Uli Geis, Mirza Rahman, Wally Landsberg, Imad Al-Dakkak, Emiel van Heumen

Publikováno v: Drug Safety

Introduction Two risk minimization (RM) tools—a healthcare professional frequently asked questions (HCP-FAQs) brochure and a patient/caregiver information brochure (PCIB)—were developed for HCPs and for adolescents (aged ≥ 13 years) receiving a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12d52fc67df1cb31a82f3f604233a31a
http://europepmc.org/articles/PMC6061424

Zobrazit plný text záznamu

Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study

Autor: Michiel W. van den Heuvel, Pierre A. M. Peeters, Alex Zwiers, Thijs van Iersel, Paul C. C. M. Passier, Emiel van Heumen, Jean Smeets

Publikováno v: Clinical drug investigation. 30(12)

Sugammadex facilitates rapid reversal of rocuronium- and vecuronium-induced neuromuscular blockade. This study aimed to evaluate the safety, tolerability and pharmacokinetics of high doses of sugammadex (up to 96 mg/kg) in healthy subjects.In this ra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f87f8b03f2c05a45653e95cc05ddd1f
https://pubmed.ncbi.nlm.nih.gov/20825252

Zobrazit plný text záznamu

Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects

Autor: Alex Zwiers, Emiel van Heumen, Paul C. C. M. Passier, Jean Smeets, Thijs van Iersel, Michiel W. van den Heuvel, Pierre A. M. Peeters

Publikováno v: Clinical Drug Investigation. :1

Background and objective Sugammadex facilitates rapid reversal of rocuronium- and vecuronium-induced neuromuscular blockade. This study aimed to evaluate the safety, tolerability and pharmacokinetics of high doses of sugammadex (up to 96 mg/kg) in he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb1dc72f27ef6e3927ec8f6c3e4fda49
https://doi.org/10.2165/11538920-000000000-00000

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání